EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
58 hedge funds and large institutions have $116M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.4M | |
| 2 | +$4.83M | |
| 3 | +$4.26M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.67M |
| 5 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$2.97M |
Top Sellers
| 1 | -$2.92M | |
| 2 | -$1.24M | |
| 3 | -$240K | |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$225K |
| 5 |
RA
Ramius Advisors
New York
|
-$168K |